Table 1.
Demographic characteristics by vaccination status for primary cases and household contacts, San Diego, CA, and Denver, CO, January–April 2021.
|
Not Vaccinated (N = 402) |
Recently Vaccinated (N = 32) |
Partially Vaccinated (N = 30) |
Fully Vaccinated (N = 29) |
Overall (N = 493) |
|
|---|---|---|---|---|---|
| Case Status | |||||
| Primary Case | 126 (31%) | 12 (38%) | 6 (20%) | 3 (10%) | 147 (30%) |
| Household Contacts | 276 (69%) | 20 (62%) | 24 (80%) | 26 (90%) | 346 (70%) |
| Age (median years, range) | 23 (0–74) | 39 (15–86) | 50 (17–74) | 48 (32–83) | 31 (0–86) |
| Sex | |||||
| Female | 201 (50%) | 19 (59%) | 17 (57%) | 21 (72%) | 258 (52%) |
| Male | 201 (50%) | 13 (41%) | 13 (43%) | 8 (28%) | 235 (48%) |
| Race/Ethnicity | |||||
| White, NH | 222 (55%) | 25 (78%) | 15 (50%) | 23 (79%) | 285 (58%) |
| Black, NH | 14 (3%) | 1 (3%) | 1 (3%) | 0 (0%) | 16 (3%) |
| AI/AN, NH | 4 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 4 (1%) |
| Asian, NH | 27 (7%) | 0 (0%) | 5 (17%) | 4 (14%) | 36 (7%) |
| NH/PI, NH | 5 (1%) | 0 (%) | 0 (0%) | 0 (0%) | 5 (1%) |
| Multi race, NH | 24 (6%) | 1 (3%) | 1 (3%) | 0 (0%) | 26 (5%) |
| Other race, NH | 2 (<1%) | 0 (0%) | 1 (3%) | 0 (0%) | 3 (1%) |
| Hispanic/Latino | 104 (26%) | 5 (16%) | 7 (23%) | 1 (3%) | 117 (24%) |
| Missing | 0 (0%) | 0 (0%) | 0 (0%) | 1 (3%) | 1 (<1%) |
| Highest Level of Education | |||||
| Child < 18 years | 167 (42%) | 3 (9%) | 1 (3%) | 0 (0%) | 171 (35%) |
| Less than High School | 15 (4%) | 1 (3%) | 3 (10%) | 0 (0%) | 19 (4%) |
| High School/GED | 47 (12%) | 2 (6%) | 5 (17%) | 2 (7%) | 56 (11%) |
| Some college | 58 (14%) | 7 (22%) | 4 (13%) | 1 (3%) | 70 (14%) |
| Technical degree/Associate’s | 18 (4%) | 0 (0%) | 1 (3%) | 0 (0%) | 19 (4%) |
| Bachelor’s degree | 68 (17%) | 14 (44%) | 10 (33%) | 17 (59%) | 109 (22%) |
| Master’s degree | 26 (7%) | 4 (13%) | 5 (17%) | 7 (24%) | 42 (9%) |
| Doctoral/professional degree | 3 (1%) | 1 (3%) | 1 (3%) | 2 (7%) | 7 (1%) |
| Enrollment Location | |||||
| San Diego, CA | 190 (47%) | 9 (28%) | 12 (40%) | 7 (24%) | 218 (44%) |
| Denver, CO | 212 (53%) | 23 (72%) | 18 (60%) | 22 (76%) | 275 (56%) |
| Medical Comorbidities | |||||
| Any Medical Condition | 130 (32%) | 14 (44%) | 23 (77%) | 16 (55%) | 183 (37%) |
| Any Chronic lung disease | 41 (10%) | 5 (16%) | 6 (20%) | 3 (10%) | 55 (11%) |
| Diabetes | 12 (3%) | 3 (9%) | 5 (17%) | 2 (7%) | 22 (4%) |
| Hypertension | 29 (7%) | 6 (19%) | 10 (10%) | 4 (14%) | 49 (10%) |
| Any Cardiovascular disease | 12 (3%) | 3 (9%) | 2 (7%) | 4 (14%) | 21 (4%) |
| Any chronic kidney disease | 4 (1%) | 1 (3%) | 0 (0%) | 0 (0%) | 5 (1%) |
| Any chronic liver disease | 1 (<1%) | 0 (0%) | 0 (%) | 2 (7%) | 3 (1%) |
| Any immunocompromising condition or medication | 12 (3%) | 1 (3%) | 2 (7%) | 1 (3%) | 16 (3%) |
| Any hyperlipidemia | 13 (3%) | 2 (6%) | 3 (10%) | 3 (10%) | 21 (4%) |
| Any hypothyroid | 8 (2%) | 2 (6%) | 3 (10%) | 3 (10%) | 16 (3%) |
| Any neurologic/ neurodevelopmental disorder | 13 (3%) | 1 (3%) | 1 (3%) | 2 (7%) | 17 (3%) |
| Other chronic condition | 47 (12%) | 5 (16%) | 8 (27%) | 5 (17%) | 65 (13%) |
| Vaccine Product | |||||
| BNT162b2 | N/A | 16 (50%) | 18 (60%) | 17 (59%) | 51 (10%) |
| mRNA-1273 | N/A | 13 (41%) | 12 (40%) | 11 (38%) | 36 (7%) |
| JNJ-78436735 | N/A | 2 (6%) | 0 (0%) | 1 (3%) | 3 (1%) |
| Missing | N/A | 1 (3%) | 0 (0%) | 0 (0%) | 1 (<1%) |
Abbreviations: AI/AN – American Indian and Alaska Native, GED – General Educational Development, NH – non-Hispanic, NH/PI – Native Hawaiian and Pacific Islander.